Advertisement

Topics

ArQule shares boosted by positive results from study of cancer-fighting inhibitor ARQ 531

07:30 EDT 14 Jun 2019 | Proactive Investors

ArQuale said ARQ 531 demonstrated substantial anti-tumor activity and a favorable safety profile

Original Article: ArQule shares boosted by positive results from study of cancer-fighting inhibitor ARQ 531

NEXT ARTICLE

More From BioPortfolio on "ArQule shares boosted by positive results from study of cancer-fighting inhibitor ARQ 531"

Advertisement
Quick Search
Advertisement
Advertisement